Primary outcome parameter | Neck Disability Index at five years’ follow-up |
Secondary outcome parameters | Core Outcome Measures Index |
Individual patient success at 12, 24, 36, 48 and 60 month defined as: | |
● Improvement of at least 17 in the Neck Disability Index (100 points) compared with baseline (adjustable according to results from own minimal clinically important change results for Neck Disability Index). | |
● Pain relief, as defined by ≥20 mm improvement on 100 mm visual analog for arm/shoulder pain | |
● Global outcome (1 or 2 on five-category Likert scale) | |
● No opiates or opiate derivatives because of neck or arm pain | |
● Absence of symptomatic device failure and re-operations at the index level | |
Pain relief, as defined by ≥20 mm improvement on 100 mm visual analog scale for neck pain and arm or shoulder pain | |
Changes in physical and mental health defined as improvement of 15% in the overall score as captured by the Short Form-12 (SF-12) version 2 questionnaire (Brazier 2005) | |
Modified Japanese Orthopedic Association score and Nurick score | |
Adjacent level degeneration: | |
● By evidence of instability, defined as sagittal plane translation >3.5 mm (20% of vertebral body anterior-posterior diameter) or sagittal plane rotation of >20° based on standing flexion or extension X-rays | |
● By evidence of disc degeneration (Miyazaki grade ≥ IV) or osteochondrosis (Modic change type I) on magnetic resonance imaging | |
● Radiographic classification (Walraevens 0 to 3) | |
● By occurrence of operation because of adjacent level disease | |
Quantitative sensory testing | |
Segmental lordosis and overall cervical sagittal alignment | |
Operative time | |
Length of hospital stay | |
Pain medication usage (including epidural injections and nerve block injections) | |
Return to work | |
Worker’s compensation | |
Direct and indirect societal costs |